Cargando…
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
BACKGROUND: The presence of lymph node (LN) metastasis is a critical prognostic factor in colorectal cancer (CRC) patients and is also an indicator for adjuvant chemotherapy. The gold standard (GS) technique for LN diagnosis and staging is based on the analysis of haematoxylin and eosin (H&E)-st...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748889/ https://www.ncbi.nlm.nih.gov/pubmed/31115896 http://dx.doi.org/10.1007/s40258-019-00482-7 |
_version_ | 1783452158485594112 |
---|---|
author | Diaz-Mercedes, Sherley Archilla, Ivan Camps, Jordi de Lacy, Antonio Gorostiaga, Iñigo Momblan, Dulce Ibarzabal, Ainitze Maurel, Joan Chic, Nuria Bombí, Josep Antoni Balaguer, Francesc Castells, Antoni Aldecoa, Iban Borras, Josep Maria Cuatrecasas, Miriam |
author_facet | Diaz-Mercedes, Sherley Archilla, Ivan Camps, Jordi de Lacy, Antonio Gorostiaga, Iñigo Momblan, Dulce Ibarzabal, Ainitze Maurel, Joan Chic, Nuria Bombí, Josep Antoni Balaguer, Francesc Castells, Antoni Aldecoa, Iban Borras, Josep Maria Cuatrecasas, Miriam |
author_sort | Diaz-Mercedes, Sherley |
collection | PubMed |
description | BACKGROUND: The presence of lymph node (LN) metastasis is a critical prognostic factor in colorectal cancer (CRC) patients and is also an indicator for adjuvant chemotherapy. The gold standard (GS) technique for LN diagnosis and staging is based on the analysis of haematoxylin and eosin (H&E)-stained slides, but its sensitivity is low. As a result, patients may not be properly diagnosed and some may have local recurrence or distant metastases after curative-intent surgery. Many of these diagnostic and treatment problems could be avoided if the one-step nucleic acid amplification assay (OSNA) was used rather than the GS technique. OSNA is a fast, automated, standardised, highly sensitive, quantitative technique for detecting LN metastases. OBJECTIVES: The aim of this study was to assess the budget impact of introducing OSNA LN analysis in early-stage CRC patients in the Spanish National Health System (NHS). METHODS: A budget impact analysis comparing two scenarios (GS vs. OSNA) was developed within the Spanish NHS framework over a 3-year time frame (2017–2019). The patient population consisted of newly diagnosed CRC patients undergoing surgical treatment, and the following costs were included: initial surgery, pathological diagnosis, staging, follow-up expenses, systemic treatment and surgery after recurrence. One- and two-way sensitivity analyses were performed. RESULTS: Using OSNA instead of the GS would have saved €1,509,182, €6,854,501 and €10,814,082 during the first, second and third years of the analysis, respectively, because patients incur additional costs in later years, leading to savings of more than €19 million for the NHS over the 3-year time horizon. CONCLUSIONS: Introducing OSNA in CRC LN analysis may represent not only an economic benefit for the NHS but also a clinical benefit for CRC patients since a more accurate staging could be performed, thus avoiding unnecessary treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-019-00482-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6748889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-67488892019-10-01 Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma Diaz-Mercedes, Sherley Archilla, Ivan Camps, Jordi de Lacy, Antonio Gorostiaga, Iñigo Momblan, Dulce Ibarzabal, Ainitze Maurel, Joan Chic, Nuria Bombí, Josep Antoni Balaguer, Francesc Castells, Antoni Aldecoa, Iban Borras, Josep Maria Cuatrecasas, Miriam Appl Health Econ Health Policy Original Research Article BACKGROUND: The presence of lymph node (LN) metastasis is a critical prognostic factor in colorectal cancer (CRC) patients and is also an indicator for adjuvant chemotherapy. The gold standard (GS) technique for LN diagnosis and staging is based on the analysis of haematoxylin and eosin (H&E)-stained slides, but its sensitivity is low. As a result, patients may not be properly diagnosed and some may have local recurrence or distant metastases after curative-intent surgery. Many of these diagnostic and treatment problems could be avoided if the one-step nucleic acid amplification assay (OSNA) was used rather than the GS technique. OSNA is a fast, automated, standardised, highly sensitive, quantitative technique for detecting LN metastases. OBJECTIVES: The aim of this study was to assess the budget impact of introducing OSNA LN analysis in early-stage CRC patients in the Spanish National Health System (NHS). METHODS: A budget impact analysis comparing two scenarios (GS vs. OSNA) was developed within the Spanish NHS framework over a 3-year time frame (2017–2019). The patient population consisted of newly diagnosed CRC patients undergoing surgical treatment, and the following costs were included: initial surgery, pathological diagnosis, staging, follow-up expenses, systemic treatment and surgery after recurrence. One- and two-way sensitivity analyses were performed. RESULTS: Using OSNA instead of the GS would have saved €1,509,182, €6,854,501 and €10,814,082 during the first, second and third years of the analysis, respectively, because patients incur additional costs in later years, leading to savings of more than €19 million for the NHS over the 3-year time horizon. CONCLUSIONS: Introducing OSNA in CRC LN analysis may represent not only an economic benefit for the NHS but also a clinical benefit for CRC patients since a more accurate staging could be performed, thus avoiding unnecessary treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-019-00482-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-05-21 2019 /pmc/articles/PMC6748889/ /pubmed/31115896 http://dx.doi.org/10.1007/s40258-019-00482-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Article Diaz-Mercedes, Sherley Archilla, Ivan Camps, Jordi de Lacy, Antonio Gorostiaga, Iñigo Momblan, Dulce Ibarzabal, Ainitze Maurel, Joan Chic, Nuria Bombí, Josep Antoni Balaguer, Francesc Castells, Antoni Aldecoa, Iban Borras, Josep Maria Cuatrecasas, Miriam Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma |
title | Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma |
title_full | Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma |
title_fullStr | Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma |
title_full_unstemmed | Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma |
title_short | Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma |
title_sort | budget impact analysis of molecular lymph node staging versus conventional histopathology staging in colorectal carcinoma |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748889/ https://www.ncbi.nlm.nih.gov/pubmed/31115896 http://dx.doi.org/10.1007/s40258-019-00482-7 |
work_keys_str_mv | AT diazmercedessherley budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT archillaivan budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT campsjordi budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT delacyantonio budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT gorostiagainigo budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT momblandulce budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT ibarzabalainitze budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT maureljoan budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT chicnuria budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT bombijosepantoni budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT balaguerfrancesc budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT castellsantoni budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT aldecoaiban budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT borrasjosepmaria budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma AT cuatrecasasmiriam budgetimpactanalysisofmolecularlymphnodestagingversusconventionalhistopathologystagingincolorectalcarcinoma |